Global Clinical Trial Leader
Genentech | |
United States, California, South San Francisco | |
Jan 13, 2026 | |
|
The Position
The Genentech Research and Early Development (gRED) Global Clinical Trial Leader (CTL) is accountable for the execution and delivery of early development global clinical trials under the leadership of the Sr. CTL. The CTL will actively contribute to the Protocol Execution Team (PET), is experienced at managing vendors, developing risk mitigation strategies and study plans. The CTL champions and supports change related to their study assignments and department goals/objectives. These complex programs focus on the rapid development of new molecular entities with limited or no clinical data, and as such, require implementation of novel and highly flexible global operational strategies. The Opportunity: Your responsibilities in this role will include:
Who you are:
Onsite presence, on our South San Francisco campus, is expected for at least 3 days a week. Relocation benefits are not available for this posting. The expected salary range for this position based on the primary location of California is $125,100 - $232,300. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance. This position also qualifies for the benefits detailed at the link provided below. Benefits #LI-JD1 Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company's policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws. If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants. | |
Jan 13, 2026